Presentations for the May 11, 2018 Joint Meeting of the Pediatric and Endocrinologic and Metabolic Drugs Advisory Committees
- Achondroplasia
Smita B. Abraham, M.D.
Office of New Drugs, Division of Metabolism and Endocrinology Products - Additional Safeguards for Children in Clinical Investigations, 21 CFR 50 Subpart D
Donna L. Snyder, M.D., F.A.A.P
FDA Office of Pediatric Therapeutics